Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000020.xml
Download PDF
CC BY-NC-ND 4.0 · Geburtshilfe Frauenheilkd
DOI: 10.1055/a-2622-6321
DOI: 10.1055/a-2622-6321
GebFra Science
Review
Polyzystisches Ovarsyndrom – Ansätze zur Begleitung und Prävention in der Jugend
Article in several languages: English | deutsch
Zusammenfassung
Adoleszente befinden sich bis 8 Jahre nach Menarche in einer Phase der Entwicklung, in der Symptome des PCOS (polyzystisches Ovarsyndrom) physiologisch sind. Daher können Diagnosekriterien für das PCOS für erwachsene Frauen nur eingeschränkt angewandt werden. Eine neue deutsche S2k-Leitlinie sowie die internationale PCOS-Leitlinie von 2023 geben standardisierte Diagnosekriterien für Hyperandrogenämie und Zyklusstörungen in der Adoleszenz vor. Zudem wird für Adoleszente, welche die Kriterien nur teilweise erfüllen, die vorläufige Diagnose PCOS at risk eingeführt, die 3 und 8 Jahre nach Menarche überprüft werden soll. Empfehlungen hinsichtlich der Therapie setzen Schwerpunkte in der Aufklärung und Lebensstilberatung der Jugendlichen und somit der Prävention und Therapie von möglichen Komorbiditäten wie Adipositas, Insulinresistenz und Hypertonie. Der vorliegende Artikel gibt einen Überblick über die strukturierte Diagnostik und Therapieelemente in der Begleitung von Adoleszenten mit PCOS.
Schlüsselwörter
polyzystisches Ovarsyndrom - Adoleszenz - Diagnosekriterien - Prävention - LeitliniePublication History
Received: 12 March 2025
Accepted after revision: 26 May 2025
Article published online:
01 August 2025
© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References/Literatur
- 1 Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 1935; 29: 181-191
- 2 Azziz R, Adashi EY. Stein and Leventhal: 80 years on. Am J Obstet Gynecol 2016; 214: 247.e1-247.e11
- 3 Berni TR, Morgan CL, Rees DA. Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study. J Clin Endocrinol Metab 2021; 106: e3369-e3380
- 4 West S, Vahasarja M, Bloigu A. et al. The impact of self-reported oligo-amenorrhea and hirsutism on fertility and lifetime reproductive success: results from the Northern Finland Birth Cohort 1966. Hum Reprod 2014; 29: 628-633
- 5 Joham AE, Norman RJ, Stener-Victorin E. et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol 2022; 10: 668-680
- 6 Stener-Victorin E, Teede H, Norman RJ. et al. Polycystic ovary syndrome. Nat Rev Dis Primers 2024; 10: 27
- 7 Hagberg CE, Spalding KL. White adipocyte dysfunction and obesity-associated pathologies in humans. Nat Rev Mol Cell Biol 2024; 25: 270-289
- 8 Neven ACH, Forslund M, Ranashinha S. et al. Prevalence and accurate diagnosis of polycystic ovary syndrome in adolescents across world regions: a systematic review and meta-analysis. Eur J Endocrinol 2024; 191: S15-S27
- 9 Pena AS, Codner E, Witchel S. Criteria for Diagnosis of Polycystic Ovary Syndrome during Adolescence: Literature Review. Diagnostics (Basel) 2022; 12: 1931
- 10 Pena AS, Witchel SF, Hoeger KM. et al. Adolescent polycystic ovary syndrome according to the international evidence-based guideline. BMC Med 2020; 18: 72
- 11 Teede HJ, Tay CT, Laven JJE. et al. International PCOS Network. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol 2023; 189: G43-G64
- 12 AWMF. Anmeldung S2k-Leitlinie Diagnostik und Therapie des polyzystischen Ovarsyndroms (PCOS). 2025 Accessed February 11, 2025 at: https://register.awmf.org/de/leitlinien/detail/089-004
- 13 Codner E, Villarroel C, Eyzaguirre FC. et al. Polycystic ovarian morphology in postmenarchal adolescents. Fertil Steril 2011; 95: 702-706.e1–2
- 14 Kelsey TW, Dodwell SK, Wilkinson AG. et al. Ovarian volume throughout life: a validated normative model. PLoS One 2013; 8: e71465
- 15 Assens M, Dyre L, Henriksen LS. et al. Menstrual Pattern, Reproductive Hormones, and Transabdominal 3D Ultrasound in 317 Adolescent Girls. J Clin Endocrinol Metab 2020; 105: dgaa355
- 16 Fulghesu AM, Canu E, Casula L. et al. Polycystic Ovarian Morphology in Normocyclic Non-hyperandrogenic Adolescents. J Pediatr Adolesc Gynecol 2021; 34: 610-616
- 17 Legro RS, Dodson WC, Kris-Etherton PM. et al. Randomized Controlled Trial of Preconception Interventions in Infertile Women With Polycystic Ovary Syndrome. J Clin Endocrinol Metab 2015; 100: 4048-4058
- 18 Mills G, Badeghiesh A, Suarthana E. et al. Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Hum Reprod 2020; 35: 1666-1674
- 19 Vink JM, Sadrzadeh S, Lambalk CB. et al. Heritability of polycystic ovary syndrome in a Dutch twin-family study. J Clin Endocrinol Metab 2006; 91: 2100-2104
- 20 Hudnut-Beumler J, Kaar JL, Taylor A. et al. Development of type 2 diabetes in adolescent girls with polycystic ovary syndrome and obesity. Pediatr Diabetes 2021; 22: 699-706
- 21 Manzano-Nunez R, Santana-Dominguez M, Rivera-Esteban J. et al. Non-Alcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome: A Systematic Review, Meta-Analysis, and Meta-Regression. J Clin Med 2023; 12: 856
- 22 Parker J, O’Brien C, Hawrelak J. et al. Polycystic Ovary Syndrome: An Evolutionary Adaptation to Lifestyle and the Environment. Int J Environ Res Public Health 2022; 19: 1336
- 23 Koivuaho E, Laru J, Ojaniemi M. et al. Age at adiposity rebound in childhood is associated with PCOS diagnosis and obesity in adulthood-longitudinal analysis of BMI data from birth to age 46 in cases of PCOS. Int J Obes (Lond) 2019; 43: 1370-1379
- 24 PCOS Selbsthilfe Deutschland e. V.. Herzlich willkommen bei der PCOS Selbsthilfe Deutschland. 2024 Accessed November 01, 2024 at: https://www.pcos-selbsthilfe.org/
- 25 MCHRI. Resources for Women with PCOS. 2024 Accessed November 01, 2024 at: https://mchri.org.au/guidelines-resources/community/pcos-resources/
- 26 Riestenberg C, Jagasia A, Markovic D. et al. Health Care-Related Economic Burden of Polycystic Ovary Syndrome in the United States: Pregnancy-Related and Long-Term Health Consequences. J Clin Endocrinol Metab 2022; 107: 575-585
- 27 Bundesinstitut für Öffentliche Gesundheit. Förderung eines gesunden Lebensstils im Kindes- und Jugendalter. 2024 Accessed January 22, 2025 at: https://www.bzga.de/was-wir-tun/ernaehrung-bewegung-entspannung/
- 28 Deutsche Gesellschaft für Ernährung. Ernährungsempfehlungen für Deutschland. 2024 Accessed January 22, 2025 at: https://www.dge.de/gesunde-ernaehrung/gut-essen-und-trinken/
- 29 Arbeitsgemeinschaft Adipositas im Kindes- und Jugendalter (AGA). Behandlungseinrichtungen (nach AGA zertifiziert). 2024 Accessed November 05, 2024 at: https://adipositas-gesellschaft.de/aga/behandlungseinrichtungen/
- 30 Marzouk TM, Sayed Ahmed WA. Effect of Dietary Weight Loss on Menstrual Regularity in Obese Young Adult Women with Polycystic Ovary Syndrome. J Pediatr Adolesc Gynecol 2015; 28: 457-461
- 31 Simon SL, Phimphasone-Brady P, McKenney KM. et al. Comprehensive transition of care for polycystic ovary syndrome from adolescence to adulthood. Lancet Child Adolesc Health 2024; 8: 443-455
- 32 Hammel MC, Stein R, Kratzsch J. et al. Fasting indices of glucose-insulin-metabolism across life span and prediction of glycemic deterioration in children with obesity from new diagnostic cut-offs. Lancet Reg Health Eur 2023; 30: 100652
- 33 AWMF. S3-Leitlinie Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter Version 4.0. 2023 Accessed July 31, 2025 at: https://register.awmf.org/de/leitlinien/detail/057-016
- 34 Lee I, Cooney LG, Saini S. et al. Increased odds of disordered eating in polycystic ovary syndrome: a systematic review and meta-analysis. Eat Weight Disord 2019; 24: 787-797
- 35 Gräfe K, Zipfel S, Herzog W. et al. Screening psychischer Störungen mit dem „Gesundheitsfragebogen für Patienten (PHQ-D)“. Diagnostica 2004; 50: 171-181
- 36 Lopez-Gil JF, Garcia-Hermoso A, Smith L. et al. Global Proportion of Disordered Eating in Children and Adolescents: A Systematic Review and Meta-analysis. JAMA Pediatr 2023; 177: 363-372
- 37 Saei Ghare Naz M, Ozgoli G, Ahmadi F. et al. Adolescents’ polycystic ovary syndrome health-related quality of life questionnaire (APQ-20): development and psychometric properties. Eur J Pediatr 2023; 182: 2393-2407
- 38 Dokras A, Sarwer DB, Allison KC. et al. Weight Loss and Lowering Androgens Predict Improvements in Health-Related Quality of Life in Women With PCOS. J Clin Endocrinol Metab 2016; 101: 2966-2974
- 39 Monash University, European Society of Endocrinology, American Society für Reproductive Medicine, Centre for Research Excellence in Women’s Health in Reproductive Life, Centre for Research Excellence in Polycystic Ovary Syndrome, eshre, Endocrine Society. Technical Report for the International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome 2023 Update. Accessed July 31, 2025 at: https://www.monash.edu/__data/assets/pdf_file/0010/3379591/TechnicalReport-2023.pdf
- 40 Reynolds RV, Yeung H, Cheng CE. et al. Guidelines of care for the management of acne vulgaris. J Am Acad Dermatol 2024; 90: 1006.e1-1006.e30
- 41 Arowojolu AO, Gallo MF, Lopez LM. et al. Combined oral contraceptive pills for treatment of acne. Cochrane Database Syst Rev 2012; (07) CD004425
- 42 Forslund M, Melin J, Alesi S. et al. Different kinds of oral contraceptive pills in polycystic ovary syndrome: a systematic review and meta-analysis. Eur J Endocrinol 2023; 189: S1-S16
- 43 Bundesinstitut für Arzneimittel und Medizinprodukte (bfarm). Anwendungsbeschränkungen von Cyproteronacetat aufgrund des Risikos für Meningeome. 2022 Accessed May 13, 2025 at: https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RHB/2020/rhb-cyproteron.html
- 44 Bundesinstitut für Arzneimittel und Medizinprodukte (bfarm). Chlormadinonacetat und Nomegestrolacetat: Maßnahmen zur Minimierung des Meningeomrisikos. Rote Hand Brief 2022. 2025 Accessed May 13, 2025 at: https://www.bfarm.de/SharedDocs/Risikoinformationen/Pharmakovigilanz/DE/RHB/2022/rhb-chlormadinon-nomegestrol.html
- 45 Al Khalifah RA, Florez ID, Dennis B. et al. Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis. Pediatrics 2016; 137: e20154089
- 46 Elkind-Hirsch KE, Chappell N, Shaler D. et al. Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study. Fertil Steril 2022; 118: 371-381
- 47 Reiser E, Lanbach J, Bottcher B. et al. Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS. J Clin Med 2022; 12: 67
- 48 Johnson JE, Daley D, Tarta C. et al. Risk of endometrial cancer in patients with polycystic ovarian syndrome: A meta-analysis. Oncol Lett 2023; 25: 168
- 49 Rosen MW, Tasset J, Kobernik EK. et al. Risk Factors for Endometrial Cancer or Hyperplasia in Adolescents and Women 25 Years Old or Younger. J Pediatr Adolesc Gynecol 2019; 32: 546-549
- 50 AWMF. S3-Leitlinie Endometriumkarzinom. 2024 Accessed May 13, 2025 at: https://register.awmf.org/de/leitlinien/detail/032-034OL
- 51 Jayasena CN, Devine K, Barber K. et al. Society for endocrinology guideline for understanding, diagnosing and treating female hypogonadism. Clin Endocrinol (Oxf) 2024; 101: 409-442
- 52 Prior JC, Shirin S, Goshtasebi A. Bone health and prevalent fractures in women with polycystic ovary syndrome: a meta-analysis and endocrine-context pathophysiology review. Expert Rev Endocrinol Metab 2023; 18: 283-293
- 53 Hancke K. PCOS – Kinderwunsch und Schwangerschaft. Geburtshilfe Frauenheilkd 2024; 84: 602-606
- 54 Berliner Transitionsprogramm. Informationen für Fach- und Hausärzte. 2024 Accessed November 05, 2024 at: https://www.btp-ev.de/berliner-transitionsprogramm/informationen-fur-fach-und-hausarzte/
- 55 Adriaansen BPH, Oude Alink SE, Swinkels DW. et al. Reference intervals for serum 11-oxygenated androgens in children. Eur J Endocrinol 2024;